Related Experiment Video
Updated: Aug 23, 2026

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
Published on: June 23, 2022
Cardiovascular complications in acromegaly
G Vitale1, R Pivonello, G Lombardi
1Department of Molecular and Clinical Endocrinology, School of Medicine, Federico II University of Naples, Naples, Italy.
Insights
Acromegaly, caused by excess growth hormone (GH) and insulin-like growth factor-I (IGF-I), significantly increases cardiovascular risks. Effective treatment can improve heart function and reduce cardiac complications in patients.
Area of Science:
- Endocrinology
- Cardiology
- Internal Medicine
Background:
- Acromegaly, a condition of excess growth hormone (GH) and insulin-like growth factor-I (IGF-I), is associated with increased cardiovascular morbidity and mortality.
- GH and IGF-I excess lead to a specific cardiomyopathy, characterized initially by a hyperkinetic syndrome.
Purpose of the Study:
- To describe the cardiac manifestations of acromegaly.
- To highlight the impact of GH/IGF-I excess on cardiac structure and function.
- To emphasize the importance of cardiac evaluation and the potential benefits of treatment.
Main Methods:
- The abstract does not specify methods, but discusses established clinical observations and pathophysiology.
- Review of literature on acromegaly and its cardiovascular complications.
Main Results:
- Acromegaly frequently causes concentric biventricular hypertrophy and diastolic dysfunction, potentially progressing to impaired systolic function and heart failure.
- Cardiac rhythm and valve abnormalities are also observed.
- Comorbidities like hypertension and diabetes worsen acromegalic cardiomyopathy.
Conclusions:
- Effective therapy suppressing GH/IGF-I may reduce left ventricular mass and improve cardiac function.
- Comprehensive cardiac assessment is essential for managing patients with acromegaly.
Abstract:
Cardiovascular morbidity and mortality are increased in acromegaly. In fact, GH and IGF-I excess induces a specific cardiomyopathy. The early stage of acromegaly is characterized by the hyperkinetic syndrome (high heart rate and increased systolic output). Frequently, concentric biventricular hypertrophy and diastolic dysfunction occur in acromegaly, leading to an impaired systolic function ending in heart failure if the disease is untreated or unsuccessfully untreated. Besides, abnormalities of cardiac rhythm and of valves have been also described in acromegaly. The coexistence of other complications, such as arterial hypertension and diabetes, aggravates the acromegalic cardiomyopathy. The suppression of GH/IGF-I following an efficacious therapy could decrease left ventricular mass and improve cardiac function. In conclusion, a careful evaluation of cardiac function, morphology and activity seems to be mandatory in acromegaly.
Related Concept Videos
Complications of Diabetes Mellitus
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Heart Failure III: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy